LivaNova (LIVN) Long-Term Investments (2015 - 2026)
LivaNova's (LIVN) quarterly Long-Term Investments came in at $57.3 million in Q2 2026, up 164.54% year-over-year from $21.7 million in Q2 2025, and up 49.68% quarter-over-quarter from $38.3 million in Q1 2026.
Analysis
LivaNova (LIVN) Long-Term Investments (2015 - 2026) Analysis & Trends
LivaNova has disclosed Long-Term Investments across 12 years of filings, most recently posting $57.3 million for Q2 2026.
- In Q2 2026, Long-Term Investments rose 164.54% year-over-year to $57.3 million; the TTM figure through Jun 2026 stood at $57.3 million (up 164.54% YoY), while the FY2025 annual figure was $36.6 million, up 45.71% from the prior year.
- Long-Term Investments came in at $57.3 million for Q2 2026 at LivaNova, up from $38.3 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $96.7 million in Q1 2022 to a low of $21.7 million in Q2 2025.
- Average Long-Term Investments over 5 years is $42.3 million, with a median of $39.0 million recorded in 2023.
- Year-over-year, Long-Term Investments surged 303.33% in 2022 and sank 67.93% in 2023.
- Over 5 years, Long-Term Investments stood at $54.4 million in 2022, then retreated by 29.23% to $38.5 million in 2023, then tumbled by 34.84% to $25.1 million in 2024, then jumped by 45.71% to $36.6 million in 2025, then surged by 56.75% to $57.3 million in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $57.3 million in Q2 2026, $38.3 million in Q1 2026, and $36.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 1.11 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 2.25 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 244.10 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | 57.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.29 Mn |
| Mar 31, 2026 | 38.28 Mn |
| Dec 31, 2025 | 36.55 Mn |
| Sep 30, 2025 | 28.01 Mn |
| Jun 30, 2025 | 21.66 Mn |
| Mar 31, 2025 | 22.72 Mn |
| Dec 31, 2024 | 25.08 Mn |
| Sep 30, 2024 | 35.37 Mn |
| Jun 30, 2024 | 39.55 Mn |
| Mar 31, 2024 | 41.62 Mn |
| Dec 31, 2023 | 38.50 Mn |
| Sep 30, 2023 | 43.67 Mn |
| Jun 30, 2023 | 42.03 Mn |
| Mar 31, 2023 | 31.01 Mn |
| Dec 31, 2022 | 54.39 Mn |
| Sep 30, 2022 | 48.22 Mn |
| Jun 30, 2022 | 61.61 Mn |
| Mar 31, 2022 | 96.72 Mn |
| Dec 31, 2021 | 16.60 Mn |
| Sep 30, 2021 | 16.58 Mn |